Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate added to standard postoperative chemoradiotherapy for newly diagnosed glioblastoma
ChiCTR-TRC-14005004Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of valproic acid in glioblastoma (GBM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Perioperative seizure occurrence rate, Late postoperative seizure occurrence rate and 4 more. Started Aug 2014; status: recruiting.
02
Drugs
valproic acid
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on ChiCTR-TRC-14005004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005004.